Document is current
Any future updates will be listed below
-
Authors
Russell, Matthew W.
Kumar, Madhukar
Li, Ang
Singh, Rishi P. http://orcid.org/0000-0001-5859-8162
Talcott, Katherine E. http://orcid.org/0000-0003-0458-4181
-
Funding
Funding for this research was provided by:
Case Western Reserve University School of Medicine | Clinical and Translational Science Collaborative of Cleveland, School of Medicine, Case Western Reserve University
Research to Prevent Blindness
- License Information
-
More Information
Article History
Received: 12 July 2023
Revised: 7 March 2024
Accepted: 11 April 2024
First Online: 27 April 2024
Competing interests
: KET reports research grants from Zeiss and Regenxbio, speaker fees from Genentech, and consulting fees from Genentech, Apellis and Eyepoint. RPS reports personal fees from Genentech/Roche, personal fees from Alcon/Novartis, grants from Apellis and Graybug, personal fees from Zeiss, personal fees from Bausch + Lomb, personal fees from Regeneron Pharmaceuticals, Inc. Inc. All other authors report no disclosures.
